Class III

Drug Recall: Nortrel (norethindrone and ethinyl estradiol tablets USP) 0.5/35, packaged in cartons, each carton contains 3 blister cards, each card contains 28 tablets, Rx only, TEVA PHARMACEUTICALS USA, INC., Nor

Teva Pharmaceuticals USA, Inc · January 25, 2024

Reason for Recall

Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.

Product Description

Nortrel (norethindrone and ethinyl estradiol tablets USP) 0.5/35, packaged in cartons, each carton contains 3 blister cards, each card contains 28 tablets, Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC 0555-9008-67

Distribution

nationwide

States Affected

NATIONWIDE

Quantity Affected

12,916 cartons

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0321-2024

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.